0

Liver Disease Collection
 81-100 of 970 Articles
Editorials |  2 July 2002
Alanine Aminotransferase Levels: What's Normal?
Marshall M. Kaplan, MD
Ann Intern Med. 2002;137(1):49-51. doi:10.7326/0003-4819-137-1-200207020-00012
Academia and the Profession |  18 June 2002
Truth Survival in Clinical Research: An Evidence-Based Requiem?
Thierry Poynard, MD, PhD; Mona Munteanu, MD; Vlad Ratziu, MD; et al.
Ann Intern Med. 2002;136(12):888-895. doi:10.7326/0003-4819-136-12-200206180-00010
Reviews |  21 May 2002
Approach to the Patient with Chronic Hepatitis C Virus Infection
Steven K. Herrine, MD
Ann Intern Med. 2002;136(10):747-757. doi:10.7326/0003-4819-136-10-200205210-00010
Brief Communications |  7 May 2002
Reversibility of Cirrhosis in Patients Cured of Thalassemia by Bone Marrow Transplantation
Pietro Muretto, MD; Emanuele Angelucci, MD; Guido Lucarelli, MD
Ann Intern Med. 2002;136(9):667-672. doi:10.7326/0003-4819-136-9-200205070-00009
Therapeutics |  May/Jun 2002
Nadolol and isosorbide prevented recurrent variceal bleeding better than did endoscopic ligation in cirrhosis
Hubert H. Nietsch, MD; Kris V. Kowdley, MD
Ann Intern Med. 2002;136(3):94. doi:10.7326/ACPJC-2002-136-3-094
Resource Corner |  May/Jun 2002
The Desktop Guide to Complementary and Alternative Medicine: An Evidence-based Approach
Kumanan Wilson, MD
Ann Intern Med. 2002;136(3):A14. doi:10.7326/ACPJC-2002-136-3-A14
Brief Communications |  16 April 2002
Severe Hepatotoxicity Associated with the Dietary Supplement LipoKinetix
Joya T. Favreau, MD; Mina L. Ryu, MD; Glenn Braunstein, MD; et al.
Ann Intern Med. 2002;136(8):590-595. doi:10.7326/0003-4819-136-8-200204160-00008
Brief Communications |  19 March 2002
Mixed Hepatocellular–Cholestatic Liver Injury after Pioglitazone Therapy
Louis D. May, MD; Jay H. Lefkowitch, MD; Michael T. Kram, MD; et al.
Ann Intern Med. 2002;136(6):449-452. doi:10.7326/0003-4819-136-6-200203190-00008
Editorials |  19 March 2002
“Did This Drug Cause My Patient's Hepatitis?” and Related Questions
David W. Nierenberg, MD
Ann Intern Med. 2002;136(6):480-483. doi:10.7326/0003-4819-136-6-200203190-00013
Brief Communications |  19 February 2002
Surprisingly Small Effect of Antiviral Treatment in Patients with Hepatitis C
Yngve Falck-Ytter, MD; Hemangi Kale, MD; Kevin D. Mullen, MD; et al.
Ann Intern Med. 2002;136(4):288-292. doi:10.7326/0003-4819-136-4-200202190-00008
Brief Communications |  15 May 2001
Effects of Long-Term Postoperative Interferon-α Therapy on Intrahepatic Recurrence after Resection of Hepatitis C Virus–Related Hepatocellular Carcinoma: A Randomized, Controlled Trial
Shoji Kubo, MD; Shuhei Nishiguchi, MD; Kazuhiro Hirohashi, MD; et al.
Ann Intern Med. 2001;134(10):963-967. doi:10.7326/0003-4819-134-10-200105150-00010
Brief Communications |  16 January 2001 FREE
The Relationship of Acute Transfusion-Associated Hepatitis to the Development of Cirrhosis in the Presence of Alcohol Abuse
D. Robert Harris, PhD; René Gonin, PhD; Harvey J. Alter, MD; et al.
Ann Intern Med. 2001;134(2):120-124. doi:10.7326/0003-4819-134-2-200101160-00012
Brief Communications |  19 December 2000
Severe Liver Injury after Treatment with the Leukotriene Receptor Antagonist Zafirlukast
John F. Reinus, MD; Seth Persky, MD; Jill S. Burkiewicz, PharmD; et al.
Ann Intern Med. 2000;133(12):964-968. doi:10.7326/0003-4819-133-12-200012190-00011
Brief Communications |  5 December 2000
Fatal Hepatorenal Failure Associated with Hydrazine Sulfate
Mark I. Hainer, DO; Naoky Tsai, MD; Steven T. Komura, MD; et al.
Ann Intern Med. 2000;133(11):877-880. doi:10.7326/0003-4819-133-11-200012050-00011
Editorials |  5 December 2000
Hydrazine, Cancer, the Internet, Isoniazid, and the Liver
Martin Black, MD; Hamid Hussain, MD
Ann Intern Med. 2000;133(11):911-913. doi:10.7326/0003-4819-133-11-200012050-00016
Articles |  7 November 2000
Watchful Waiting with Periodic Liver Biopsy versus Immediate Empirical Therapy for Histologically Mild Chronic Hepatitis C: A Cost-Effectiveness Analysis
John B. Wong, MD; Raymond S. Koff, MD
Ann Intern Med. 2000;133(9):665-675. doi:10.7326/0003-4819-133-9-200011070-00008
Brief Communications |  7 November 2000
Methylene Blue Improves the Hepatopulmonary Syndrome
Peter Schenk, MD; Christian Madl, MD; Shahrzad Rezaie-Majd, MD; et al.
Ann Intern Med. 2000;133(9):701-706. doi:10.7326/0003-4819-133-9-200011070-00012
Editorials |  7 November 2000
Methylene Blue and Cirrhosis: Pathophysiologic Insights, Therapeutic Dilemmas
Michael B. Fallon, MD
Ann Intern Med. 2000;133(9):738-740. doi:10.7326/0003-4819-133-9-200011070-00016
Articles |  5 September 2000
The Effect of HFE Genotypes on Measurements of Iron Overload in Patients Attending a Health Appraisal Clinic
Ernest Beutler, MD; Vincent Felitti, MD; Terri Gelbart, BS; et al.
Ann Intern Med. 2000;133(5):329-337. doi:10.7326/0003-4819-133-5-200009050-00008
Articles |  15 August 2000
Efficacy and Safety of Troglitazone in the Treatment of Lipodystrophy Syndromes
Elif Arioglu, MD; Jennifer Duncan-Morin, RN; Nancy Sebring, RD; et al.
Ann Intern Med. 2000;133(4):263-274. doi:10.7326/0003-4819-133-4-200008150-00009
Advertisement
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)